Catalyst Wire Dossier Catalyst Wire Dossier

Rhokiinsa

netarsudil · Santen Oy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rhokiinsa, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: EMA Authorised: Rhokiinsa (netarsudil) — Santen Oy

See pricing